Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accommodate, adding, admitted, Adult, afflict, Aid, assigned, ATM, avoid, backlog, bacterial, blinded, Bologna, branded, Breakthrough, Brescia, cancelling, catalyst, ceased, certainty, CMS, Colombia, contacted, contemplating, contra, COVID, CRO, CRRT, cybersecurity, datashowing, debilitating, debuted, destabilize, destined, difficult, discontinuation, discontinued, DMC, drop, environment, epidemic, essential, EUA, expedite, explore, exposure, FACC, FESC, FSCAI, futility, hacker, Hemoscien, imminent, interfere, intermittently, introduce, irreversibly, joined, justifying, knowledge, la, Lanka, leverage, magnitude, mainland, Marino, MD, meaningful, membrane, MHRA, mid, milestone, mission, NAMSA, NMPA, older, outbreak, oxygenation, pandemic, para, pause, paused, Payroll, penalty, perfusion, PerLife, phishing, PPP, preliminary, preservation, preserving, problem, QSR, quantitate, quickly, ramp, reassessment, reassigned, recurrent, refractory, rehabilitating, Relief, remote, repaid, respond, restart, restarted, resume, revoked, run, running, San, Sanitary, SBA, short, slowdown, Society, solid, sophisticated, specialty, spread, Sri, stage, steady, stroke, subsidize, Taiwan, Taiwanese, Task, temporarily, transcend, UAE, unforeseen, unusually, urgent, USD, Variability, variable, Vatican, verbal, version, visibility, vital, weaning, week, wepresented, Wuhan
Removed:
absorption, add, adherence, adulterated, advertise, African, allegedly, AlphaMedix, Alternatively, applicant, appointment, approvable, Armaghan, arrangement, Arsak, assure, ban, bench, Bosnia, Canada, Canadian, Cardiotec, Chong, choose, clarification, classification, classified, clause, coma, comparable, complemented, composition, conclude, consult, contracting, convened, Croatia, deem, deeming, denying, descriptive, designated, detain, determination, discounted, DOJ, drawn, DRGR, enjoin, equivalence, Eric, Estonia, exclusively, exempt, exported, faced, false, family, FASB, filtration, flat, foresee, forward, Gad, hepatic, Herzegovina, Hoang, implement, incorporating, indefinitely, inducing, ineffective, initiate, inspection, Inspector, investing, Ireland, issuing, Japan, Justice, kind, Kish, Korean, KRA, labeled, Lap, Latvia, Lebanon, legally, lessee, Lithuania, long, Ltda, Mar, marginal, Medica, metabolic, Mexican, misbranded, modifying, Moldova, monitor, Montenegro, Mortensen, neighboring, notify, opened, orSM, outweighing, packaging, Palex, panel, passed, path, payer, payor, permission, pertaining, Pharmaworld, play, poisoning, Portugal, pose, predicate, prohibited, promoting, provision, Pty, Qatar, reached, recall, reclassified, referral, referring, refund, register, regulated, regulating, reimbursable, remuneration, repealing, resolved, restrain, Revilla, rewarding, Romania, SA, Salamat, Scanmed, seize, servicing, shorter, SIA, Smart, Spain, standing, Stark, Statute, submission, substantive, suitable, Sunshine, supplier, surveillance, taxable, taxation, TCJA, TekMed, threshold, timeframe, top, Topic, transparency, Trump, unreasonable, urge, Vascular, veterinary, virtually, Welfare
Filing tables
Filing exhibits
Associated CTSO transcripts
CTSO similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION OF
PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Phillip Chan, Chief Executive Officer of CytoSorbents Corporation, hereby certify, that, to my knowledge:
1. | The Quarterly Report on Form 10-Q for the quarter ending March 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in such Quarterly Report on Form 10-Q for the quarter ending March 31, 2020, fairly presents, in all material respects, the financial condition and results of operations of CytoSorbents Corporation. |
Date: May 5, 2020 |
CYTOSORBENTS CORPORATION |
By:/s/ Phillip P. Chan |
Phillip Chan Chief Executive Officer |